Validation of the Expanded Hammersmith Functional Motor Scale in Spinal Muscular Atrophy Type II and III
- 21 September 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 26 (12), 1499-1507
- https://doi.org/10.1177/0883073811420294
Abstract
The relationships between the Expanded Hammersmith Functional Motor Scale (HFMSE) and genotype and motor and respiratory outcomes were examined in patients with spinal muscular atrophy types II and III (n = 70). The correlation between the HFMSE and Gross Motor Function Measure was r = 0.98. Correlations between HFMSE and forced vital capacity (percentage of predicted normal) (n = 56) and a functional rating (n = 57) were r = 0.87 and r = 0.92, respectively. Correlations with strength were as follows: knee extension, r = 0.74 (n = 60); elbow flexion, r = 0.77 (n = 61); and knee flexion, r = 0.74 (n = 58). The HFMSE differentiated patients by SMN2 copy number (P = .0007); bi-level positive airway pressure use, P < .0001); ambulatory status (P < .0001); and spinal muscular atrophy type (P < .0001). The HFMSE demonstrates significant associations with established measures of function, strength, and genotype, and discriminates patients based on function, diagnostic category, and bi-level positive airway pressure need. Time of administration averaged 12 minutes. The HFMSE is a valid, time-efficient outcome measure for clinical trials in spinal muscular atrophy types II and III.Keywords
This publication has 26 references indexed in Scilit:
- Assessing upper limb function in nonambulant SMA patients: Development of a new moduleNeuromuscular Disorders, 2011
- SMN Deficiency Causes Tissue-Specific Perturbations in the Repertoire of snRNAs and Widespread Defects in SplicingCell, 2008
- Perspectives on Clinical Trials in Spinal Muscular AtrophyJournal of Child Neurology, 2007
- Fishing for a Mechanism: Using Zebrafish to Understand Spinal Muscular AtrophyJournal of Child Neurology, 2007
- Issues in SMA clinical trial design: The International Coordinating Committee (ICC) for SMA Subcommittee on SMA Clinical Trial DesignNeuromuscular Disorders, 2007
- Challenges in drug development for muscle disease: A stakeholders' meetingMuscle & Nerve, 2006
- A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophyNeuromuscular Disorders, 2006
- The gross motor function measure™ is a valid and sensitive outcome measure for spinal muscular atrophyNeuromuscular Disorders, 2006
- Spinal Muscular AtrophyNeuroepidemiology, 1999
- Identification and characterization of a spinal muscular atrophy-determining geneCell, 1995